Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 4 |
2022 | 2 |
2023 | 1 |
2024 | 0 |
PubMed for Bookshelf ID: 5531358
6 results
Results by year
Filters applied: . Clear all
Page 1
Mobocertinib (Exkivity) for non-small cell lung cancer.
Med Lett Drugs Ther. 2022 Nov 28;64(1664):e197-e198.
Med Lett Drugs Ther. 2022.
PMID: 36397196
No abstract available.
FDA Approval Summary: Mobocertinib for Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations.
Duke ES, Stapleford L, Drezner N, Amatya AK, Mishra-Kalyani PS, Shen YL, Maxfield K, Zirkelbach JF, Bi Y, Liu J, Zhang X, Wang H, Yang Y, Zheng N, Reece K, Wearne E, Glen JJ, Ojofeitimi I, Scepura B, Nair A, Bikkavilli RK, Ghosh S, Philip R, Pazdur R, Beaver JA, Singh H, Donoghue M.
Duke ES, et al.
Clin Cancer Res. 2023 Feb 1;29(3):508-512. doi: 10.1158/1078-0432.CCR-22-2072.
Clin Cancer Res. 2023.
PMID: 36112541
Free PMC article.
Clinical Trial.
Item in Clipboard
Properties of FDA-approved small molecule protein kinase inhibitors: A 2022 update.
Roskoski R Jr.
Roskoski R Jr.
Pharmacol Res. 2022 Jan;175:106037. doi: 10.1016/j.phrs.2021.106037. Epub 2021 Dec 15.
Pharmacol Res. 2022.
PMID: 34921994
Review.
Item in Clipboard
Mobocertinib: First Approval.
Markham A.
Markham A.
Drugs. 2021 Nov;81(17):2069-2074. doi: 10.1007/s40265-021-01632-9.
Drugs. 2021.
PMID: 34716908
Review.
Item in Clipboard
Treatment Outcomes and Safety of Mobocertinib in Platinum-Pretreated Patients With EGFR Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer: A Phase 1/2 Open-label Nonrandomized Clinical Trial.
Zhou C, Ramalingam SS, Kim TM, Kim SW, Yang JC, Riely GJ, Mekhail T, Nguyen D, Garcia Campelo MR, Felip E, Vincent S, Jin S, Griffin C, Bunn V, Lin J, Lin HM, Mehta M, Jänne PA.
Zhou C, et al.
JAMA Oncol. 2021 Dec 1;7(12):e214761. doi: 10.1001/jamaoncol.2021.4761. Epub 2021 Dec 16.
JAMA Oncol. 2021.
PMID: 34647988
Free PMC article.
Clinical Trial.
Item in Clipboard
Activity and Safety of Mobocertinib (TAK-788) in Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations from a Phase I/II Trial.
Riely GJ, Neal JW, Camidge DR, Spira AI, Piotrowska Z, Costa DB, Tsao AS, Patel JD, Gadgeel SM, Bazhenova L, Zhu VW, West HL, Mekhail T, Gentzler RD, Nguyen D, Vincent S, Zhang S, Lin J, Bunn V, Jin S, Li S, Jänne PA.
Riely GJ, et al.
Cancer Discov. 2021 Jul;11(7):1688-1699. doi: 10.1158/2159-8290.CD-20-1598. Epub 2021 Feb 25.
Cancer Discov. 2021.
PMID: 33632775
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite